Nicotine’s Effects on the Brain & Body & How to Quit Smoking or Vaping

Nicotine primarily increases dopamine in the mesolimbic reward pathway, leading to feelings of reward and motivation. It also boosts acetylcholine, which acts like an attentional spotlight for neural circuits, and elevates norepinephrine (adrenaline), increasing overall alertness and energy.

Yes, nicotine suppresses appetite and increases metabolism by about 2-5% through its effects on POMC neurons in the hypothalamus. This mechanism not only reduces food cravings but also limits the impulse to chew, explaining why some people, particularly younger females, use nicotine for weight control.

Nicotine increases heart rate, blood pressure, and heart contractibility, increasing sympathetic tone and physical readiness. It also constricts blood vessels, leading to reduced blood flow to various tissues and potentially causing sexual dysfunction, like decreased penile girth.

Smoking, vaping, dipping, and snuffing severely damage endothelial cells that line blood vessels, impairing nutrient delivery to all organs. These methods introduce high levels of carcinogens like tar, ammonia, formaldehyde, and carbon dioxide, significantly increasing risks of cancer, stroke, heart attack, peripheral vascular disease, and cognitive decline, reducing lifespan by an estimated 14 years per pack smoked per day.

Vaping causes nicotine to enter the bloodstream more rapidly than smoking, leading to a faster and steeper increase in dopamine release in the brain's reward pathways. This speed of onset is a critical factor in how reinforcing and addictive a substance becomes, making vaping exceptionally hard to quit.

The success rate for quitting smoking cold turkey without any assistance is exceedingly low, only about 5%. Of those who initially succeed, 65% relapse within a year, highlighting the powerful addictive nature of nicotine and the challenges of withdrawal.

Clinical hypnosis, as developed by Dr. David Spiegel, has shown a 23% success rate for complete smoking cessation with just one session. This method involves the patient directing their own brain changes toward specific behavioral goals, remapping neural circuits to reduce the impulse to smoke or vape.

Pharmacological approaches include drugs like Bupropion (Wellbutrin), which increases dopamine and norepinephrine to offset withdrawal symptoms, raising success rates to about 20%. Nicotine replacement therapies like patches, gum, and nasal sprays are also used, often in combination, to provide variable nicotine levels and prevent the system from expecting a fixed dopamine reward.

The first week is critical because the body's homeostatic mechanisms, which had adjusted to counteract the nicotine-induced dopamine spikes, now cause dopamine levels to drop below baseline after cessation. This results in significant withdrawal symptoms, making people feel worse than before they started using nicotine, leading to high relapse rates.